Get started
Author

Yikan Wang

Observed name: Wang, Yikan
ORCID: 0009-0007-5022-3949
Observed ORCID: 0009-0007-5022-3949
OpenAlex ID: A5089588735
Deep Learning-Enhanced Adaptive Interface for Improved Accessibility in E-Government Platforms
2024 · Xiang Li, Yikan Wang · 7
Comment on “Disability is an independent predictor of mortality in patients with spinal cord injury”
2026 · Yikan Wang, Derong Bao · Journal of the Formosan Medical Association · 1
A Machine Learning Framework for Dynamic Risk Assessment and Anomaly Detection in Database Security
2025 · Qiming Xu, Le Liu, et al. · International Journal of Pattern Recognition and Artificial Intelligence · 1
Fatigue-Aware Adaptive Interfaces for Wearable Devices Using Deep Learning
2025 · Wang, Yikan · arXiv (Cornell University) · 1
PDF
Abstract LB-324: Genomic consequences of aberrant DNA repair stratify ovarian cancer histotypes
2016 · Yikan Wang, Ali Bashashati, et al. · Cancer Research · 1
Comment on “Tumor Budding Is a Promising Indicator for Elective Neck Dissection in Node‐Negative Early‐Stage Oral Squamous Cell Carcinoma: A Retrospective Cohort Study”
2026 · Jiangzhen Xie, Yikan Wang, et al. · Oral Diseases
PDF
Research on AI-driven interaction adaptation and operation behavior prediction for users with disabilities
2026 · Yikan Wang, Le Liu, et al.
Application of Multi Level Energy Consumption Modeling in Optimizing and Accelerating the Whole Process System of Machine Learning
2026 · Le Liu, Yikan Wang, et al.
Innovation in Economic and Financial Management Models Based on Big Data Technology Analysis
2025 · Qiming Xu, Yikan Wang, et al. · International Journal of Information Technologies and Systems Approach
A random forest-based study of abnormal usage pattern recognition in office space
2025 · Yikan Wang, Shenghan Zhao, et al.
Accessible Gesture-Driven Augmented Reality Interaction System
2025 · Wang, Yikan · arXiv (Cornell University)
PDF
Abstract GS03-04: Novel Mechanisms of CDH1 Inactivation in Breast Invasive Lobular Carcinoma Unveiled by the Integration of Artificial Intelligence and Genomics
2024 · Fresia Pareja, Higinio Dopeso, et al. · Cancer Research
Abstract P5-02-33: Deep learning-based assessment of HER2-low expression on breast cancer H&E digital whole slide images
2023 · Gerard Oakley III, Jorge Reis-Filho, et al. · Cancer Research
Abstract PR13: TERT is frequently mutated in adult-type granulosa cell tumors of the ovary compared to other malignant sex cord-stromal tumors
2018 · Jessica A. Pilsworth, Dawn R. Cochrane, et al. · Clinical Cancer Research
Abstract B22: Capturing L1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers as a way to track tumor development
2018 · Zhouchunyang Xia, Dawn Cochrane, et al. · Clinical Cancer Research
Abstract PR03: Arginine deprivation as a potential targeted therapy for clear cell ovarian carcinoma
2018 · Jennifer Xiao Ye Ji, Dawn R. Cochrane, et al. · Clinical Cancer Research
Abstract 3381: TERT promoter mutation in granulosa cell tumours of the ovary: Prevalence and prognostic significance
2017 · Jessica A. Pilsworth, Dawn R. Cochrane, et al. · Cancer Research
Abstract AS18: The somatic mutational landscape of endometriosis associated ovarian cancers and precursor lesions
2015 · Michael S Anglesio, Ali Bashashati, et al. · Clinical Cancer Research
Abstract LB-312: The somatic mutational landscape of ovarian clear cell carcinoma and its precursor lesions
2014 · Ali Bashashati, Michael Anglesio, et al. · Cancer Research
Reverse-Engineering of Genetic Regulatory Pathways in Human Cancer
2013 · Yikan Wang · ResearchSpace (University of Auckland)
Works count: 20
Citation count: 11
H-index: 1
I10-index:
Year
Topic
Type